SAN FRANCISCO, August 06, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials in the Company’s registrational ...

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

All three trials in the Company’s registrational ECLIPSE program for chronic hepatitis delta (CHD) have now been initiated.

If a program is running in the background on your Windows 11/10 PC & you can see it on Taskbar or Task Manager but is not visible on your desktop screen, see this post.

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

New quantum computing system allows multiple users to run programs simultaneously using virtual machines.

Action News Jax’s Ben Becker has learned that the company now operating the Jacksonville Housing Authority’s Housing Choice Voucher Program is under federal scrutiny.

Analyst David Pollack pinpoints which college football team has the best running back room in the nation.

Notre Dame running backs coach Ja'Juan Seider during a Notre Dame football spring practice at Irish Athletic Center on Wednesday, March 26, 2025, in South Bend.